Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older editNewer edit →
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 5: Line 5:
Part 2
Part 2
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00043-Goo-tek ++ TAG-00318-Fun-nzi ++ TAG-00008-Cli-ngK
|RefTagsOriginal=
|RefModule=1
|RefTagsFR=
|RefUnit=1.3.0
}}
}}


Line 15: Line 15:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 1 — Unit 1.3.0
|-
|-
! Scope
! Scope
Line 32: Line 35:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00043-Goo-tek|Good clinical practice]], [[Glossary:TAG-00318-Fun-nzi|Fundamentals]], [[Glossary:TAG-00008-Cli-ngK|Clinical trial]]
|-
! Tags (original language)
|
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
Validity area GBR
Scope(s) HM
Document name The Medicines for Human Use (Clinical Trials) Regulations 2004
Version / Revision 01-May-2004
Status Current
Document type Legal act
Language(s) EN
Description The Medicines for Human Use (Clinical Trials) Regulations 2004
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.3.0
Scope HM
Document part Schedule 1

Part 2

Language EN
Original entry by Florian Adragna
Contributors
Tags Good clinical practice, Fundamentals, Clinical trial
Comment GCP principles based on ICH E6

Content

CONDITIONS AND PRINCIPLES WHICH APPLY TO ALL CLINICAL TRIALS Principles based on International Conference on Harmonisation GCP Guideline

Retrieved from "https://gxplex.org/index.php?title=Reference:GBR_The_Medicines_for_Human_Use_(Clinical_Trials)_Regulations_2004_01-May-2004_Schedule_1_Part_2&oldid=14485"